Genetics

This blog post examines a metabolome-wide Mendelian randomization study that investigated whether genetically predicted differences in circulating metabolites contribute causally to multiple sclerosis risk. By integrating large metabolomic and multiple sclerosis genome-wide association datasets, the researchers prioritized 29 candidate metabolites, including serine, lysine, acetone, acetoacetate, uridine, and lipids carried within specific VLDL and HDL subclasses. The findings highlight potentially important connections between amino-acid metabolism, ketone-body metabolism, lipoprotein composition, immune regulation, and myelin biology, while also emphasizing that genetic causal estimates require experimental validation before being translated into biomarkers, dietary guidance, or therapeutic interventions.